Linscomb & Williams Inc. Decreases Holdings in Laboratory Co. of America Holdings (NYSE:LH)

Linscomb & Williams Inc. decreased its position in shares of Laboratory Co. of America Holdings (NYSE:LHGet Rating) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,944 shares of the medical research company’s stock after selling 146 shares during the period. Linscomb & Williams Inc.’s holdings in Laboratory Co. of America were worth $4,381,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the stock. Geode Capital Management LLC lifted its position in Laboratory Co. of America by 3.3% during the third quarter. Geode Capital Management LLC now owns 1,835,046 shares of the medical research company’s stock valued at $515,142,000 after acquiring an additional 59,057 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Laboratory Co. of America by 2.2% during the third quarter. Dimensional Fund Advisors LP now owns 1,591,004 shares of the medical research company’s stock valued at $447,843,000 after acquiring an additional 34,864 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Laboratory Co. of America by 2.5% during the fourth quarter. JPMorgan Chase & Co. now owns 1,280,094 shares of the medical research company’s stock valued at $402,218,000 after acquiring an additional 30,756 shares during the last quarter. Northern Trust Corp lifted its position in Laboratory Co. of America by 1.5% during the fourth quarter. Northern Trust Corp now owns 1,176,755 shares of the medical research company’s stock valued at $369,749,000 after acquiring an additional 17,820 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Laboratory Co. of America by 8.3% during the third quarter. Bank of New York Mellon Corp now owns 1,141,093 shares of the medical research company’s stock valued at $321,147,000 after acquiring an additional 87,162 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

In other news, CMO Amy B. Summy sold 249 shares of Laboratory Co. of America stock in a transaction dated Thursday, March 10th. The shares were sold at an average price of $262.21, for a total value of $65,290.29. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director R Sanders Williams sold 572 shares of Laboratory Co. of America stock in a transaction dated Friday, March 25th. The shares were sold at an average price of $272.98, for a total transaction of $156,144.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,177 shares of company stock worth $874,306. 0.31% of the stock is owned by company insiders.

A number of research firms have issued reports on LH. Truist Financial decreased their price target on shares of Laboratory Co. of America from $350.00 to $320.00 in a report on Friday, April 29th. StockNews.com began coverage on shares of Laboratory Co. of America in a report on Thursday, March 31st. They issued a “buy” rating for the company. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Laboratory Co. of America from $294.00 to $265.00 in a report on Tuesday, May 3rd. Mizuho decreased their price target on shares of Laboratory Co. of America from $354.00 to $323.00 in a report on Wednesday, May 4th. Finally, Credit Suisse Group decreased their price target on shares of Laboratory Co. of America from $344.00 to $312.00 in a report on Monday, May 2nd. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Laboratory Co. of America currently has a consensus rating of “Buy” and a consensus target price of $302.88.

Shares of Laboratory Co. of America stock opened at $242.38 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.98 and a quick ratio of 1.81. The firm has a fifty day moving average price of $262.99 and a 200 day moving average price of $276.30. Laboratory Co. of America Holdings has a 1 year low of $232.01 and a 1 year high of $317.17. The stock has a market cap of $22.47 billion, a PE ratio of 11.12 and a beta of 1.04.

Laboratory Co. of America (NYSE:LHGet Rating) last issued its earnings results on Thursday, April 28th. The medical research company reported $6.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.88 by $0.23. The firm had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $4.01 billion. Laboratory Co. of America had a net margin of 13.24% and a return on equity of 23.84%. The firm’s revenue was down 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $8.79 earnings per share. As a group, equities analysts expect that Laboratory Co. of America Holdings will post 19.9 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 9th. Investors of record on Thursday, May 19th will be given a dividend of $0.72 per share. The ex-dividend date is Wednesday, May 18th. This represents a $2.88 annualized dividend and a yield of 1.19%.

About Laboratory Co. of America (Get Rating)

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Read More

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Co. of America Holdings (NYSE:LHGet Rating).

Institutional Ownership by Quarter for Laboratory Co. of America (NYSE:LH)

Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.